Differences may exist between TRM populations, given that TRM extracted from NSCLC and melanoma do not express CTLA-4 [20,89] and TRM originating from ovarian cancer only weakly express CTLA-4, TIM-3 and LAG-3 [127]. Here, CTLA4 is linked to melanoma.